# Dexamethasone Dose for Postoperative Nausea and Vomiting Prophylaxis in Obese Patients

> **NCT04538820** · PHASE4 · UNKNOWN · sponsor: **Diskapi Yildirim Beyazit Education and Research Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Postoperative Nausea and Vomiting

## Interventions

- **DRUG:** Dexamethasone 4 mg IV-control
- **DRUG:** Dexamethasone 4 mg IV
- **DRUG:** Dexamethasone 8 mg IV

## Key facts

- **NCT ID:** NCT04538820
- **Lead sponsor:** Diskapi Yildirim Beyazit Education and Research Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-01
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-09-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2021-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04538820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04538820, "Dexamethasone Dose for Postoperative Nausea and Vomiting Prophylaxis in Obese Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04538820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*